Mackenzie Financial Corp Biomarin Pharmaceutical Inc Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 72,734 shares of BMRN stock, worth $4.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

72,734

Previous 30,474 138.68%

Holding current value

$4.79 Million

Previous $2.51 Million 103.83%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $2.92 Million - $3.97 Million	42,260 Added 138.68%	72,734 $5.11 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $359,645 - $445,607	4,832 Added 18.84%	30,474 $2.51 Million
Q1 2024 May 10, 2024	SELL	$83.81 - $99.0 $836,423 - $988,020	-9,980 Reduced 28.02%	25,642 $2.24 Million
Q4 2023 Jan 30, 2024	SELL	$76.22 - $98.51 $51,372 - $66,395	-674 Reduced 1.86%	35,622 $3.43 Million
Q3 2023 Oct 25, 2023	BUY	$85.07 - $94.48 $534,239 - $593,334	6,280 Added 20.92%	36,296 $3.21 Million
Q2 2023 Aug 03, 2023	SELL	$86.68 - $100.3 $1.36 Million - $1.58 Million	-15,720 Reduced 34.37%	30,016 $2.6 Million
Q1 2023 Apr 24, 2023	BUY	$87.74 - $117.27 $70,192 - $93,816	800 Added 1.78%	45,736 $4.45 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $175,213 - $235,183	2,165 Added 5.06%	44,936 $4.65 Million
Q3 2022 Oct 07, 2022	SELL	$82.16 - $96.94 $2.56 Million - $3.02 Million	-31,204 Reduced 42.18%	42,771 $3.63 Million
Q2 2022 Aug 10, 2022	SELL	$71.48 - $86.85 $3 Million - $3.65 Million	-41,988 Reduced 36.21%	73,975 $6.13 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $272,681 - $340,264	-3,671 Reduced 3.07%	115,963 $8.94 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $2.48 Million - $3.16 Million	34,580 Added 40.66%	119,634 $10.6 Million
Q3 2021 Nov 08, 2021	BUY	$74.77 - $85.47 $1.92 Million - $2.19 Million	25,620 Added 43.11%	85,054 $6.57 Million
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $134,860 - $151,434	-1,786 Reduced 2.92%	59,434 $4.96 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $3.98 Million - $4.83 Million	53,279 Added 670.94%	61,220 $4.62 Million
Q4 2020 Feb 10, 2021	BUY	$72.61 - $90.2 $72,827 - $90,470	1,003 Added 14.46%	7,941 $696,000
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $135,546 - $247,122	1,886 Added 37.33%	6,938 $528,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $87,982 - $137,387	1,106 Added 28.03%	5,052 $623,000
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $281,626 - $382,170	3,946 New	3,946 $333,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $3.7 Million - $4.32 Million	-46,057 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $5.43 Million - $6.36 Million	-64,523 Reduced 58.35%	46,057 $4.09 Million
Q4 2018 Feb 06, 2019	BUY	$80.14 - $106.07 $8.86 Million - $11.7 Million	110,580 New	110,580 $9.42 Million

Others Institutions Holding BMRN

# of Institutions

648

Shares Held

180M

Call Options Held

2.03M

Put Options Held

1.29M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Biomarin Pharmaceutical Inc Transaction History